跳至主要内容
临床试验/NCT06830369
NCT06830369招募中不适用

Effect of a Virtual Reality Program on Patient Comfort in the Surgical Intensive Care Unit of a French University Hospital: Study Protocol for a Monocentric, Prospective, Superiority, Randomized Controlled Trial, With Blinded End-point (PROBE), ZION Study

Centre Hospitalier Universitaire, Amiens1 个研究点 分布在 1 个国家目标入组 194 人开始时间: 2025年9月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
194
试验地点
1
主要终点
IPREA questionnaire value

研究概览

简要总结

Admission to a surgical intensive care unit (ICU) following major surgery is associated with a number of discomforts, not only related to the disease itself, but also to the care provided or the ICU environment itself (lights, sounds, pain, sleep deprivation, thirst...). This discomfort is real, and can be associated with psychological consequences. The investigators hypothesized that the use of immersive virtual reality (IVR) with HypnoVR® is feasible and can help reduce discomfort in intensive care.The ZION trial is a prospective, monocentric trial, randomizing 194 patients admitted in a surgical intensive care unit after a major surgery. The inclusion criterion are patients admitted in a surgical intensive care for at least 48 hours following major surgery (cardiac, thoracic or major abdominal surgery). Patients will be allocated to the intervention group (n=97) or the control group (n=97). In the intervention group, patients will receive IVR using HypnoVR®, twice a day, during the ICU stay (2 to 5 days). In the control group, postoperative care will be conducted according to standard cares without IVR. The primary endpoint will be the 18-items IPREA questionnaire on the day of ICU discharge. The secondary endpoints will include intensity of discomfort symptoms (anxiety, pain, dyspnea, thirst and sleep deprivation), incidence of delirium, cumulative morphine consumption at ICU discharge, length of ICU stay, and anxiety or depression at 1 month after discharge from intensive care and patient experience of device use.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients over 18 years old
  • •scheduled for a major surgery (cardiothoracic surgery or a major abdominal surgery)
  • •Written informed consent from patient.
  • •Admitted in a surgical ICU for a postoperative care for at least 48 hours.
  • •Absence of delirium at inclusion (RASS and CAM-ICU scale)

排除标准

  • •Missing informed consent
  • •Patient strictly under 18 years old
  • •Inclusion in other study within the last 30 days
  • •Pregnancy
  • •Emergency hospitalization
  • •Progressive sepsis
  • •Patient transferred from another intensive care unit
  • •Short-term life-threatening condition
  • •Active psychiatric illness requiring antidepressant, antipsychotic or anxiolytic treatment
  • •Mechanical ventilation > 48 hours
  • •Patient known to have cognitive disorders.
  • •Unbalanced epilepsy
  • •Visual problems (absence of binocular vision, blindness) and/or auditory problems (deafness) preventing the use of virtual reality
  • •Pregnant or breast-feeding women
  • •Patients under guardianship or deprived of their liberty
  • •Patients not registered with the national social security system

研究组 & 干预措施

intervention group

Experimental

干预措施: HypnoVR (Device)

standard group

Active Comparator

干预措施: usual health care (Other)

结局指标

主要结局

IPREA questionnaire value

时间窗: at the day of ICU-discharge from intensive care, within 5 days

The primary endpoint will be the 18-item IPREA questionnaire on the day of ICU discharge from intensive care. Each item of the questionnaire includes factors such as noise, light, bed, sleep, thirst, hunger, cold, heat, pain, medical device, intimacy, anxiety, isolation, visiting hours, phone, information, breath and depression. It represents a valid French questionnaire on self-perceived discomfort in intensive care, which is the only discomfort assessment instrument validated for use in the ICU.

次要结局

  • Length of stay (in days)(At ICU discharge day (within 5 days))
  • Intensity of discomfort symptoms(at the day of ICU-discharge from intensive care, within 5 days)
  • Cumulative opioid consumption (morphine or oxycodone)(At ICU discharge day (within 5 days))
  • Anxiety and depression at 1 month(at 1 month after discharge from intensive care)
  • Patient experience score(At ICU discharge day (within 5 days))
  • Delirium incidence(daily until ICU discharge (within 5 days))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验